Olivier F.
- Country
- France
- Department
- Radiothérapie
Research Overview
- TRANSCRIPT: An open label, controlled, randomized multicentric international study evaluating the benefit of autologous stem cell transplantation after complete response in frontline setting patients with T cell-lymphoma
- A Phase 3 Randomized Study Comparing Odronextamab and Lenalidomide Versus Rituximab and Lenalidomide in Relapsed/Refractory Follicular and Marginal Zone Lymphoma
- Phase 3 Study of Acalabrutinib with R-CHOP in Patients Aged ≤75 with Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma
Data & Insights
Has run more than one trial at 98 of 209 partner sites.
Specializations
Lymphoma Research
This investigator specializes in various forms of lymphoma, with particular emphasis on Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL). Their research extends to novel therapeutic approaches including tazemetostat combinations and odronextamab-based treatments.
- B-cell lymphoma innovations
- Combined therapy approaches
- T-cell lymphoma treatments
Their work includes investigation of autologous stem cell transplantation in peripheral T-cell lymphoma patients.
Multiple Myeloma Studies
The investigator focuses on developing treatments for newly diagnosed multiple myeloma, particularly in transplant-ineligible patients. Their research encompasses minimal residual disease adapted strategies.
- Novel therapeutic combinations
- Subcutaneous treatment delivery
- Frail patient populations
Research includes evaluation of isatuximab-based combinations and lenalidomide therapies.
Therapeutic Innovation
The investigator explores targeted therapy combinations across various hematologic malignancies. Their work includes evaluation of novel antibody treatments and their integration with established therapeutic regimens.
- Response assessment strategies
- Treatment optimization
- High-risk patient management
Focus areas include chemotherapy combinations and immunotherapy approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.